Overview

Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray

Status:
Completed
Trial end date:
2017-01-27
Target enrollment:
Participant gender:
Summary
A single center, study of 20 subjects to assess 4 weeks of therapy with Topicort® twice daily BID and 12 weeks twice daily on 2 consecutive days to patients with scalp psoriasis
Phase:
Phase 4
Details
Lead Sponsor:
Psoriasis Treatment Center of Central New Jersey
Collaborator:
Taro Pharmaceuticals USA
Treatments:
Desoximetasone